2018 Pan Pacific Lymphoma Conference
L

Immunotherapy Advances and Updates: Overview of Immunology

By 2018 Pan Pacific Lymphoma Conference FEATURING Laura Zitella
By 2018 Pan Pacific Lymphoma Conference FEATURING Laura Zitella
2,177 views
August 15, 2018
3 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
53:42
PleXus Communications

Managing Women's Health in Menopause: Evolving Approaches for t…

Feat. J. Simon, T. Iyer, A. Fiffick, M. Minkin
11:43
University of Colorado Department of Medicine

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Feat. L. Kondapalli
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
23:02
Cleveland Clinic Taussig Cancer Institute

Pulmonary Complications of Checkpoint Inhibitor Therapy

Feat. M. Smith
21:45
International Congress on Cancer Metastasis

Immunotherapy and Targeted Therapy for Personalized Cancer Treatment

Feat. K. Kim
19:28
OncoAlert

Cutaneous Toxicity in Oncology: Mechanism and Management

Feat. P. Bhargava
52:19
UNC Lineberger Comprehensive Cancer Center

CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities

Feat. M. Mcelfresh
30:53
Beth Israel Deaconess Medical Center

The Role of the Intestinal Microbiome in Cancer Immunotherapy

Feat. M. Van Den Brink
21:48
Houston Methodist Hospital

Tumor-Infiltrating Lymphocytes for Clinicians

Feat. S. Ganguly
41:34
MedNews Week

Cancer and Cardiovascular Disease: The Conjoined Twins

Feat. R. Moudgil
08:40
PrecisCa

Managing Common Toxicities From CDK4/6i

Feat. E. Shonkwiler
34:35
Beth Israel Deaconess Medical Center

Updates in T-Cell Immunotherapies

Feat. C. Wu
16:27
Insights from 2023 SITC Annual Meeting

SITC 2023 Insights: "AI-Designed Personalized Neoantigen Vaccin…

Feat. D. Kleine-Kohlbrecher
21:26
NYU Langone

Common TKI Toxicity Management in 2L HCC Treatment

Feat. J. Wu
21:43
Yale Cancer Center

The Role of Surgery After Neoadjuvant Systemic Therapy for Cancer

Feat. C. Balch
03:48
GRACE

NSCLC Trials for Patients With Actionable Mutations and the Importan…

Feat. J. Rotow, P. Iyengar, T. Leal
17:19
Kate Young

Optimal Toxicity Management in mRCC

44:24
McMaster University Department of Medicine

Immune Checkpoint Inhibitor Toxicities in the ICU: A Review

Feat. A. Zereshkian, R. Gerber, L. Spatafora
31:49
Oncology Data Advisor

Predicting Immune-Related Adverse Events Through Machine Learning

Feat. W. Haque, M. Hadfield, O. Sharon
48:25
Dana-Farber Cancer Institute

Behind the Breakthroughs: Activating the Immune System to Prevent Ca…

Feat. I. Ghobrial, S. Syngal, M. Yurgelun, B. Ebert